Methotrexate vs Raltegravir Potassium
Methotrexate vs Raltegravir Potassium: Overview
This comparison examines the pharmacological differences between Methotrexate and Raltegravir Potassium.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Raltegravir Potassium β Small molecule.